WAM
GMVDW

Warberg Asset Management’s G Medical Innovations Holdings Ltd. Warrants GMVDW Stock Holding History

Warberg Asset Management’s Portfolio GMVDW Stock Details GMVDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-87,576
Closed -$7K – 328
2022
Q3 		$7K Sell
87,576
-1,519
-2% -$122 ﹤0.01% 254
2022
Q2 		$8K Sell
89,095
-200
-0.2% -$41 ﹤0.01% 221
2022
Q1 		$45K Buy
89,295
+76,494
+598% +$42.5K 0.01% 164
2021
Q4 		$4K Sell
12,801
-12,799
-50% -$5.01K ﹤0.01% 199
2021
Q3 		$10K Buy
+25,600
New +$17.2K ﹤0.01% 191

Other funds holding GMVDW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Warberg Asset Management's GMVDW Position: Q4 2022 in Review

Warberg Asset Management sold out of G Medical Innovations Holdings Ltd. Warrants (GMVDW) in Q4 2022, closing a stake of 87,576 shares — an estimated $7K sold.

Warberg Asset Management first reported a position in GMVDW in Q3 2021 and held it in 5 quarters. The position peaked at $45K in Q1 2022. 1 fund tracked by Wall St. Rank holds GMVDW as of Q4 2022.

  • Warberg Asset Management reported no remaining G Medical Innovations Holdings Ltd. Warrants position as of Q4 2022 after selling out during the quarter.
  • Warberg Asset Management sold 87,576 G Medical Innovations Holdings Ltd. Warrants shares in Q4 2022, an estimated $7K.
  • Warberg Asset Management first reported a position in G Medical Innovations Holdings Ltd. Warrants in Q3 2021 and held it in 5 quarters.
  • Warberg Asset Management's G Medical Innovations Holdings Ltd. Warrants position peaked at $45K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Warrants as of Q4 2022.

Based on Warberg Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.